Please wait


.2


Revvity, Inc. and Subsidiaries
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS



The unaudited pro forma condensed consolidated financial statements presented herein have been prepared in accordance with Article 11 of Regulation S-X and are based upon the Company’s audited consolidated financial statements for the year ended December 28, 2025 and the unaudited consolidated financial statements for the three months ended April 5, 2026 and certain assumptions, as set forth in the notes to unaudited pro forma condensed consolidated financial statements, that the Company believes are reasonable. The unaudited pro forma condensed consolidated balance sheet is presented as if the sale had been completed on April 5, 2026 and the unaudited pro forma condensed consolidated statements of operations are presented as if the sale had been completed on December 30, 2024. The pro forma adjustments presented herein are based on estimates and certain information that is currently available and may change as additional information becomes available. The unaudited pro forma condensed consolidated financial statements are not necessarily indicative of the results of operations or the financial position that would have resulted had the sale of China IDX been completed at the beginning of or as of the periods presented, nor is it indicative of the results of operations in future periods or the future financial position of the Company.


Revvity, Inc. and Subsidiaries
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET
AS OF APRIL 5, 2026

(In thousands)HistoricalDisposition and Pro Forma AdjustmentsPro Forma
Current assets:
   Cash and cash equivalents $860,320 $5,101 (a), (b)$865,421 
   Accounts receivable, net691,380 (100,133)(a)591,247 
   Inventories, net387,505 (6,694)(a)380,811 
   Other current assets189,112 61,038 (a), (b)250,150 
         Total current assets2,128,317 (40,688)2,087,629 
Property, plant and equipment, net465,636 (14,375)(a)451,261 
Operating lease right-of-use assets, net163,254 (4,462)(a)158,792 
Intangible assets, net2,306,534 (132,284)(a)2,174,250 
Goodwill6,610,750 (35,000)(a)6,575,750 
Other assets, net322,099 42,123 (a), (b)364,222 
         Total assets$11,996,590 $(184,686)(a)$11,811,904 
Current liabilities:
   Current portion of long-term debt$575,831 $— $575,831 
   Accounts payable169,679 (5,635)(a)164,044 
   Accrued expenses and other current liabilities493,134 1,314 (a)494,448 
         Total current liabilities1,238,644 (4,321)1,234,323 
Long-term debt2,632,072 $— 2,632,072 
Long-term liabilities800,859 (34,730)(a), (b)766,129 
Operating lease liabilities142,276 (3,140)(a)139,136 
         Total liabilities4,813,851 (42,191)4,771,660 
         Total stockholders' equity7,182,739 (142,495)(a), (b)7,040,244 
         Total liabilities and stockholders' equity$11,996,590 $(184,686)$11,811,904 
PREPARED IN ACCORDANCE WITH GAAP
        












Revvity, Inc. and Subsidiaries
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED INCOME STATEMENTS

Three Months Ended April 5, 2026Three Months Ended March 30, 2025
(In thousands, except per share data) HistoricalDisposition and Pro Forma AdjustmentsPro FormaHistoricalDisposition and Pro Forma AdjustmentsPro Forma
Revenue$711,118 $(24,206)(c)$686,912 $664,762 $(36,064)(c)$628,698 
Cost of revenue 323,463 (14,297)(c)309,166 289,216 (17,839)(c)271,377 
Selling, general and administrative expenses 253,882 (14,106)(c)239,776 249,719 34,004 (c), (d)283,723 
Research and development expenses 57,887 — 57,887 53,597 — 53,597 
Operating income from continuing operations 75,886 4,197 80,083 72,230 (52,229)20,001 
Interest income (6,304)10 (c)(6,294)(10,081)13 (c)(10,068)
Interest expense 24,718 — 24,718 22,964 — 22,964 
Change in fair value of investments4,204 — 4,204 (3,073)— (3,073)
Other expense, net 3,276 (711)(c)2,565 10,038 (611)(c)9,427 
Income from continuing operations, before income taxes 49,992 4,898 54,890 52,382 (51,631)751 
Provision for income taxes 9,099 501 (c)9,600 10,713 6,196 (c), (d)16,909 
Income from continuing operations 40,893 4,397 45,290 41,669 (57,827)(16,158)
(Loss) income from discontinued operations (175)— (175)568 — 568 
Net income $40,718 $4,397 $45,115 $42,237 $(57,827)$(15,590)
Diluted earnings per share:
Income from continuing operations $0.37 $0.40 $0.35 $(0.13)
(Loss) income from discontinued operations(0.00)(0.00)0.00 0.00 
Net income $0.36 $0.40 $0.35 $(0.13)
Weighted average diluted shares of common stock outstanding111,876 111,876 120,233 120,233 
 ABOVE PREPARED IN ACCORDANCE WITH GAAP





Revvity, Inc. and Subsidiaries
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED INCOME STATEMENTS

Twelve Months Ended December 28, 2025
(In thousands, except per share data) HistoricalDisposition and Pro Forma AdjustmentsPro Forma
Revenue$2,856,051 $(164,552)(c)$2,691,499 
Cost of revenue 1,291,686 (99,558)(c)1,192,128 
Selling, general and administrative expenses 991,890 (14,301)(c), (d)977,589 
Research and development expenses 215,840 — 215,840 
Operating income from continuing operations 356,635 (50,693)305,942 
Interest income (31,103)76 (c)(31,027)
Interest expense 92,185 — 92,185 
Change in fair value of investments11,456 — 11,456 
Other expense, net 15,820 (2,765)(c)13,055 
Income from continuing operations, before income taxes 268,277 (48,004)220,273 
Provision for income taxes 28,394 2,307 (c), (d)30,701 
Income from continuing operations 239,883 (50,311)189,572 
Income from discontinued operations 1,318 — 1,318 
Net income $241,201 $(50,311)$190,890 
Diluted earnings per share:
Income from continuing operations $2.06 $1.63 
Income from discontinued operations0.01 0.01 
Net income $2.07 $1.64 
Weighted average diluted shares of common stock outstanding116,595 116,595 
 ABOVE PREPARED IN ACCORDANCE WITH GAAP





Revvity, Inc. and Subsidiaries
NOTES TO UNAUDITED PRO FORMA CONDENSED CONSOLIDATED INCOME STATEMENTS


1.Pro Forma Adjustments

(a) To eliminate all historical assets and liabilities of China IDX.
(b) To reflect a potential consideration from the sale of China IDX of $140 million, which includes certain liabilities to be transferred and excludes certain contingent consideration.
(c) To eliminate the historical revenues and expenses of China IDX.
(d) Includes the loss on the probable disposition of China IDX of $55 million, including tax impacts.